News

UK celebrates opening of new Coldstream research facility ‘The CoRE’

Oct 7, 2022

Representatives from the University of Kentucky, the Woodbury Corporation and state and local officials celebrated the official opening of The CoRE — Collaboration. Research. Entrepreneurship facility at UK’s Coldstream Research Campus. The $15 million development offers early stage, high-tech companies office and laboratory space in an environment where they can further develop and commercialize their products and services.

Coldstream Executive Director, George Ward on 'Develop Lex' Podcast

Sep 16, 2022

In this episode of 'Develop Lex', Coldstream Executive Director, George Ward talks about the relationship between the University of Kentucky and Lexington, UK Real Estate Development, and the Coldstream Research Campus. DevelopLex is a podcast diving into the ins & outs of real estate development and investing here in Lexington, Kentucky. This series will feature interviews with some of Lexington's most prominent real estate developers that have played a major role in building Lexington into what it is today.

Kinetic Breaks Ground on Coldstream Research Campus

May 24, 2022

LEXINGTON, KY., – Kinetic by Windstream broke ground on its’ new regional headquarters located on the Coldstream Research campus. When complete, the building will support operations across the company’s 18-state footprint. Kinetic executives were joined by local dignitaries including Congressman Andy Barr; Ashli Watts, president and CEO of the Kentucky Chamber; Bob Quick, president and CEO of Commerce Lexington; and Eli Capilouto, President of the University of Kentucky.

Coldstream Research Campus CoRE Building Project Update

Apr 26, 2022

The new CoRE Building in the Coldstream Research Campus continues to make progress with the expected ribbon cutting happening in June. The project’s recent accomplishments include:

Coldstream-Based Tempur Sealy to Acquire United Kingdom’s Leading Specialty Bed Retailer, Dreams

May 27, 2021

Tempur Sealy International, Inc., the world’s largest bedding provider based on the Coldstream Research Campus at the University of Kentucky, announced it has executed an agreement to acquire Dreams, the leading specialty bed retailer in the United Kingdom, primarily from an affiliate of Sun Capital Partners, Inc. The transaction will accelerate Tempur Sealy's growth in the largest European bedding market and sixth largest economy in the world.

UK, Cityscape Residential Break Ground on New Residential Village

Jenny Wells-Hosley May 26, 2021

Today, representatives from the University of Kentucky and Cityscape Residential as well as local officials broke ground on what will soon become a residential village on the Coldstream Research Campus. The 260-unit, multi-family residential complex will offer Coldstream’s high-tech workforce the ability to live, work, play and innovate all within the research campus. The residential village will be named FIFTEEN51 Apartments, based on the address at 1551 Aristides Boulevard.

Altimmune Partners With Coldstream-based Summit Biosciences to Develop Intranasal COVID-19 Vaccine

Te’Asiah Partridge and Jenny Wells-Hosley Mar 26, 2021

Summit Biosciences, a high-tech company based on the University of Kentucky’s Coldstream Research Campus, has been selected by Altimmune Inc. to further develop Altimmune’s intranasal COVID-19 vaccine.

UK and Woodbury Corporation Groundbreaking

UK, Partners Break Ground on New Coldstream Research Lab

Feb 23, 2021

Representatives from the University of Kentucky, the Woodbury Corporation and state and local officials broke ground on what will soon become a home for early stage, high-tech companies from across Kentucky.

UK HDI Provides Leadership Around New State Employment First Executive Order

Aug 7, 2020

LEXINGTON, Ky. (Aug. 7, 2020) — On June 29, 2020, Gov. Andy Beshear signed the Employment First Executive Order, stating that “It is the policy of the Commonwealth of Kentucky that competitive integrated employment in the community shall be considered the first and primary option for persons with disabilities of working age who desire to become employed.”

Summit Biosciences Retained to Develop and Supply AT-301 Nasal Spray for Clinical Study

May 28, 2020

On May 28th, 2020, Atossa Therapeutics, Inc. announced their second COVID-19 therapeutic development program, AT-301 Nasal Spray.

Phone	859.231.8324
Email	coldstream@uky.edu

News

Filter News